Month: January 2021

The pandemic has posed unprecedented challenges for patient care — difficulties faced each day by clinicians, clinical engineers, IT specialists, supply chain managers, and other healthcare professionals. As a result, ECRI notes in its 14th annual report on the top 10 health technology hazards, that a number of new threats to patient and staff safety
0 Comments
Recently approved setmelanotide (Imcivree) showed promise as a treatment for severe obesity arising from genetic variants in the MC4R pathway, Rhythm Pharmaceuticals announced. Overweight or obesity could be detrimental to brain health, potentially magnifying Alzheimer’s disease. (The Journal of Alzheimer’s Disease) A large study found no link between metformin and the development of breast cancer
0 Comments
Dr. Michael Osterholm, Regents Professor, McKnight Presidential Endowed Chair in Public Health, and director of the Center for Infectious Disease Research and Policy at the University of Minnesota, announced advances for COVID-19 testing in Minnesota, Wednesday, April 22, 2020 in St. Paul, MN. Glen Stubbe | Star Tribune | Getty Images An epidemiologist who advised
0 Comments
29 January 2021 — AstraZeneca’s COVID-19 vaccine has been recommended for conditional marketing authorisation (CMA) in the European Union (EU) for active immunisation to prevent COVID-19 caused by SARS-CoV-2, in individuals 18 years of age and older. Following review of the application, the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines
0 Comments
There’s nothing wrong with setting lofty fitness goals for yourself, but what happens when you fall behind, start skipping workouts, or lose motivation? What if you’re too daunted to even start? It’s amazing how quickly fitness stops feeling fun and starts to become a chore. That’s why we came up with POPSUGAR’s first-ever 28-Day Fitness
0 Comments
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. The federal government has issued a directive that aims to bolster the COVID-19 vaccination workforce, by letting physicians, nurses, pharmacists, and other healthcare professionals return to work even if their license has expired, as long as it expired within the past
0 Comments
Founder of Mental Health Mates, writer and podcast host Bryony Gordon shares her thoughts about working on wellness, understanding your inner voice, and building personal resilience Chatting with Bryony Gordon is like picking up a conversation you put on hold to answer the door. It feels familiar, every day, and easy. She has a knack
0 Comments
Patients with progressive mesothelioma obtained a first-ever survival improvement with nivolumab (Opdivo) as second-line therapy, a randomized trial showed. Median overall survival (OS) increased by almost 40%, and the progress-free interval also improved significantly with the immune checkpoint inhibitor as compared with placebo. In particular, a significant clinical benefit was evidence in patients with epithelioid
0 Comments
If you are in the I-hate-going-to-the-dentist’s camp because you have sensitive teeth, please let us make this suggestion: You can make those visits easier by simply taking care of our own oral health.  And that starts with brushing your teeth twice a day, with the best toothpaste to serve your regular brushing needs. But getting
0 Comments
They say that the most romantic meal is the one you cook at home. So for this Valentine’s Day, we put together this 5-course meal for you and your partner. If you stick with one serving from each of these recipes, you’d only consume about 20g of net carbs for the entire meal. And yes,
0 Comments
A cross-institutional research group has revealed for the first time in the world that infants with symptomatic congenital cytomegalovirus (CMV) infection who were treated with a combination of immunoglobulin fetal therapy and neonatal therapy with antiviral drugs were less likely to experience the severe aftereffects associated with the infection than those who only received the
0 Comments
odevixibat Treatment for Progressive Familial Intrahepatic Cholestasis (PFIC) Albireo Announces U.S. FDA Acceptance of New Drug Application for Odevixibat BOSTON, Jan. 25, 2021 (GLOBE NEWSWIRE) – Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical-stage rare liver disease company developing novel bile acid modulators, today announced that the U.S. Food and Drug Administration (FDA) has accepted the Company’s New Drug Application (NDA) for
0 Comments
Nagoya University researchers and colleagues have revealed that colorectal cancer tissues contain at least two types of fibroblasts (a type of cells found in connective tissue), namely, cancer-promoting fibroblasts and cancer-restraining fibroblasts, and that the balance between them is largely involved in the progression of colorectal cancer. Their findings, recently published in the journal Gastroenterology,
0 Comments
January 28, 2021 (RARITAN, N.J.) – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced new data from the Phase 1 CHRYSALIS study, which evaluated amivantamab in patients with metastatic or unresectable non-small cell lung cancer (NSCLC) and epidermal growth factor receptor (EGFR) exon 20 insertion mutations whose disease progressed on or after platinum-based chemotherapy.1 These
0 Comments
Of all the unsung heroes of this plague-time, perhaps those who have endured the most are resident physicians. After graduation from medical school, resident doctors spend three to seven years in intensive specialty training before they can practice independently. Residency is a vestige of apprenticeships from a bleaker past. It is chapter in life when
0 Comments
After alarming testing results, the FDA has taken unprecedented action against importing hand sanitizers from Mexico. A new import alert, the first ever category-wide alert issued for an entire country, places all hand sanitizers coming from Mexico under increased scrutiny and FDA entry reviews. This news comes hot on the heels of a rubbing alcohol
0 Comments
A new report combining forecasting and expert prediction data, predicts that 125,000 lives could be saved by the end of 2021 if 50% or more of the U.S. population initiated COVID vaccination by March 1, 2021. “Meta and consensus forecast of COVID-19 targets,” developed by Thomas McAndrew, a computational scientist and faculty member at Lehigh
0 Comments